Hemodialysis Vascular Grafts Market Size (2024 - 2029)

Hemodialysis Vascular Grafts Market Analysis

The Hemodialysis Vascular Grafts Market size is estimated at USD 259.84 million in 2024, and is expected to reach USD 329.41 million by 2029, growing at a CAGR of 4.86% during the forecast period (2024-2029).

Factors such as the increasing prevalence of end-stage renal disease (ESRD) and the rising geriatric population are expected to drive the market growth. For instance, as per the article published in the journal Kidney International Supplements in April 2022, chronic kidney disease (CKD) has affected over 10% of the general population worldwide to date. CKD accentuates the demand for hemodialysis since hemodialysis is one of the major options for treating advanced kidney failure and helping the kidneys from failure.

An increase in the geriatric population is expected to support the market growth since these age groups are more prone to acquiring chronic diseases and demand the adoption of hemodialysis vascular grafts. For instance, according to the October 2023 update by the World Health Organization (WHO), the estimated geriatric population in the European region is expected to exceed those under 15 in 2024. The number of functional nephrons decreases with aging, and the remaining nephrons may become less efficient. These age-related changes reduce the ability to filter waste products and maintain fluid and electrolyte balance. This led to increased demand for hemodialysis vascular grafts, driving market growth.

Also, various clinical trials for developing hemodialysis vascular grafts are expected to drive market growth. For instance, in April 2023, Xeltis presented six-month data from its first-in-human (FIH) aXess vascular graft trial at the 13th Congress of the Vascular Access Society in Porto, Portugal. aXess is a vascular access graft intended for chronic kidney disease (CKD) patients requiring hemodialysis. Thus, an increase in positive outcomes from the clinical trial is expected to increase the chance for market approval and availability of hemodialysis vascular grafts, thereby driving market growth.

Hence, owing to the high prevalence of CKD in the geriatric population and positive outcomes from clinical trials regarding vascular grafts, the hemodialysis vascular grafts market is anticipated to grow during the forecast period. However, high cost and alternative treatment options are expected to restrain the growth of the global market during the forecast period.

Hemodialysis Vascular Grafts Industry Segmentation

As per the report's scope, hemodialysis vascular grafts or arteriovenous (AV) grafts are medical devices used to connect an artery and a vein in people who need hemodialysis. They are designed to be durable, provide adequate blood flow rates for efficient dialysis, and resist infection and clotting.

The hemodialysis vascular grafts market is segmented by raw material and geography. By raw material, the market is segmented into polyester, polytetrafluoroethylene, polyurethane, and biological materials. By biological material, the market is segmented into human saphenous & umbilical veins and tissue-engineered materials. By geography, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD) for the above segments.